Clinical audit and long-term evaluation of renal transplant recipients

Transplantation

Volumn 72, Issue 12 SUPPL., 2001, Pages

  Short, C D ^a   Russell, S ^a   Valentine, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; GRAFT SURVIVAL; HEALTH CARE; HEALTH SERVICE; HUMAN; HYPERLIPIDEMIA; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; OSTEOPOROSIS; PATIENT EDUCATION; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR;

EID: 0035670489     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Improved graft survival after renal transplantation in the United States, 1988 to 1996
2. Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors
3. Recommendations for the outpatient surveillance of renal transplant recipients
4. Posttransplant medical complications
5. Renal transplantation: Current status, complications and prevention
6. Perirenal lymphocyst formation in renal transplant recipients: Diagnosis and pathogenesis
7. Excessive polyuria after renal transplantation
8. Recurrent and de novo glomerulonephritis in the renal allograft
9. Recurrent primary disease and de novo nephritis following renal transplantation
10. Post-transplantation outcome of patients with hemolytic-uremic syndrome: Update
11. Recurrent and de novo glomerular disease after renal transplantation
12. Posttransplant malignancies
13. Malignancies complicating organ transplantation
14. Cancers in renal transplant recipients
15. Epidemiology of cancer in patients with renal transplants
16. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporine regimens
17. Posttransplantation skin cancer: Scope of the problem, management, and role for systemic retinoid chemoprevention
18. Long-term management of the liver transplant recipient
19. Evolution and etiology of cardiovascular diseases in renal transplant recipients
20. Ischemic heart disease - Major cause of death and graft loss after renal transplantation in Scandinavia
21. The role of death in kidney graft failure
22. Management strategies for post-transplant hypertension
23. Impact and management of hyperlipidemia posttransplantation
24. Impact and management of posttransplant diabetes mellitus
25. The role of lipid lowering in transplantation
26. A practical guide to the management of hypertension in renal transplant recipients
27. Anemia following renal transplantation: Erythropoietin response and iron deficiency
28. High prevalence of erectile dysfunction after renal transplantation
29. Evaluation of erectile function in renal transplant recipients